EU policy to secure safe and timely access to advanced therapies for patients 

Hosted by MEP Billy Kelleher (Renew Europe, Ireland), Co-chair of the MEP Interest Group

With the recent European Commission communication on boosting the biomanufacturing and biotechnology sector, and Mario Draghi’s report on the EU’s competitiveness, innovative health technologies are set to become one of the EU’s key tools for driving Europe’s competitive edge forward. This ambition can only be achieved through a cohesive and comprehensive approach to the proposed Pharmaceutical Package, Biotech Act and other legislative tools set to influence the development of, and patient access to, Advanced Therapy Medicinal Products (ATMPs) in the years to come.

Join us for the relaunch of the TRANSFORM MEP Interest Group for the 10th mandate of the European Parliament, as we reiterate our shared commitment to fostering a patient-centric innovation ecosystem for ATMPs in Europe. 

**Due to room capacity limitations, please note there are limited places for in-person attendance. Your request for in-person attendance will be final upon approval by the Secretariat and receipt of a confirmation email. We apologise for the inconvenience. We hope you are able to follow the event online even if you are unable to attend in-person!**